Cargando…
Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model
Malaria continues being a high-impact disease regarding public health worldwide; the WHO report for malaria in 2018 estimated that ~219 million cases occurred in 2017, mostly caused by the parasite Plasmodium falciparum. The disease cost the lives of more than 400,000 people, mainly in Africa. In sp...
Autores principales: | Lambraño, Jennifer, Curtidor, Hernando, Avendaño, Catalina, Díaz-Arévalo, Diana, Roa, Leonardo, Vanegas, Magnolia, Patarroyo, Manuel E., Patarroyo, Manuel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012257/ https://www.ncbi.nlm.nih.gov/pubmed/32083140 http://dx.doi.org/10.1155/2019/3832513 |
Ejemplares similares
-
IMPIPS: The Immune Protection-Inducing Protein Structure Concept in the Search for Steric-Electron and Topochemical Principles for Complete Fully-Protective Chemically Synthesised Vaccine Development
por: Patarroyo, Manuel Elkin, et al.
Publicado: (2015) -
Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: Potential TB vaccine candidate antigen
por: Cifuentes, Diana P, et al.
Publicado: (2010) -
Using the PfEMP1 Head Structure Binding Motif to Deal a Blow at Severe Malaria
por: Patarroyo, Manuel E., et al.
Publicado: (2014) -
Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective
por: Curtidor, Hernando, et al.
Publicado: (2017) -
Annotation and characterization of the Plasmodium vivax rhoptry neck protein 4 (PvRON4)
por: Arévalo-Pinzón, Gabriela, et al.
Publicado: (2013)